Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome-like Clinical Presentation in Human Immunodeficiency Virus-infected Children in Malawi.

El-Mallawany NK, Kamiyango W, Villiera J, Peckham-Gregory EC, Scheurer ME, McAtee CL, Allen CE, Kovarik CL, Frank D, Eason AB, Caro-Vegas C, Chiao EY, Schutze GE, Ozuah NW, Mehta PS, Kazembe PN, Dittmer DP.

Clin Infect Dis. 2019 Mar 22. pii: ciz250. doi: 10.1093/cid/ciz250. [Epub ahead of print]

PMID:
31102440
2.

A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America.

Coffey AM, Lewis A, Marcogliese AN, Elghetany MT, Punia JN, Chang CC, Allen CE, McClain KL, Gaikwad AS, El-Mallawany NK, Curry CV.

Pediatr Blood Cancer. 2019 May 16:e27798. doi: 10.1002/pbc.27798. [Epub ahead of print]

PMID:
31099136
3.

Psychiatric and Behavioral Causes of Altered Mental Status.

Allen CE, Burger RK.

Pediatr Ann. 2019 May 1;48(5):e201-e204. doi: 10.3928/19382359-20190425-02. Review.

PMID:
31067336
4.

Reliability and Findings From an Instrument Examining Sexual Assault Disclosure Content and Context: The Sexual Assault Inventory of Disclosure.

Pinciotti CM, Allen CE, Milliken JM, Orcutt HK, Sasson S.

Violence Vict. 2019 Apr 1;34(2):260-295. doi: 10.1891/0886-6708.VV-D-17-00161.

PMID:
31019012
5.

Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition.

Eckstein OS, Visser J, Rodriguez-Galindo C, Allen CE; NACHO-LIBRE Study Group.

Blood. 2019 Apr 11;133(15):1691-1694. doi: 10.1182/blood-2018-10-878363. Epub 2019 Feb 4. No abstract available.

PMID:
30718231
6.

Capacity building: a novel pediatric hematology-oncology fellowship program in sub-Saharan Africa.

Lubega J, Airewele G, Frugé E, Wilson-Lewis K, Ishigami E, Cubbage M, Waswa P, Kambugu J, Allen CE, Slone J, Mehta PS, Poplack DG.

Blood Adv. 2018 Nov 30;2(Suppl 1):11-13. doi: 10.1182/bloodadvances.2018GS112742. No abstract available.

7.

Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease.

El-Mallawany NK, Villiera J, Kamiyango W, Peckham-Gregory EC, Scheurer ME, Allen CE, McAtee CL, Legarreta A, Dittmer DP, Kovarik CL, Chiao EY, Martin SC, Ozuah NW, Mehta PS, Kazembe PN.

Infect Agent Cancer. 2018 Nov 9;13:33. doi: 10.1186/s13027-018-0207-4. eCollection 2018.

8.

Sexual selection contributes to partial restoration of phenotypic robustness in a butterfly.

Nieberding CM, San Martin G, Saenko S, Allen CE, Brakefield PM, Visser B.

Sci Rep. 2018 Sep 25;8(1):14315. doi: 10.1038/s41598-018-32132-8.

9.

Langerhans-Cell Histiocytosis.

Allen CE, Merad M, McClain KL.

N Engl J Med. 2018 Aug 30;379(9):856-868. doi: 10.1056/NEJMra1607548. Review. No abstract available.

PMID:
30157397
10.

Hepatobiliary Dysfunction and Disseminated Intravascular Coagulation Increase Risk of Mortality in Pediatric Hemophagocytic Lymphohistiocytosis.

Goldman J, Desai MS, McClain KL, Tcharmtchi MH, Kennedy CE, Thompson K, Lam F, Bashir DA, Chinn IK, Goldberg BR, Allen CE, Nguyen TC.

Pediatr Crit Care Med. 2018 Oct;19(10):e522-e530. doi: 10.1097/PCC.0000000000001684.

PMID:
30113519
11.

Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.

Allen CE, Marsh R, Dawson P, Bollard CM, Shenoy S, Roehrs P, Hanna R, Burroughs L, Kean L, Talano JA, Schultz KR, Pai SY, Baker KS, Andolina JR, Stenger EO, Connelly J, Ramirez A, Bryant C, Eapen M, Pulsipher MA.

Blood. 2018 Sep 27;132(13):1438-1451. doi: 10.1182/blood-2018-01-828277. Epub 2018 Jul 11.

PMID:
29997222
12.

Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest.

Lewis GD, Agrusa JE, Teh BS, Gramatges MM, Kothari V, Allen CE, Paulino AC.

Pract Radiat Oncol. 2018 Sep - Oct;8(5):e364-e368. doi: 10.1016/j.prro.2018.01.007. Epub 2018 Feb 4.

PMID:
29730281
13.

The role of parental and perinatal characteristics on Langerhans cell histiocytosis: characterizing increased risk among Hispanics.

Peckham-Gregory EC, McClain KL, Allen CE, Scheurer ME, Lupo PJ.

Ann Epidemiol. 2018 Aug;28(8):521-528. doi: 10.1016/j.annepidem.2018.04.005. Epub 2018 Apr 17.

PMID:
29724524
14.

Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis.

Chinn IK, Eckstein OS, Peckham-Gregory EC, Goldberg BR, Forbes LR, Nicholas SK, Mace EM, Vogel TP, Abhyankar HA, Diaz MI, Heslop HE, Krance RA, Martinez CA, Nguyen TC, Bashir DA, Goldman JR, Stray-Pedersen A, Pedroza LA, Poli MC, Aldave-Becerra JC, McGhee SA, Al-Herz W, Chamdin A, Coban-Akdemir ZH, Jhangiani SN, Muzny DM, Cao TN, Hong DN, Gibbs RA, Lupski JR, Orange JS, McClain KL, Allen CE.

Blood. 2018 Jul 5;132(1):89-100. doi: 10.1182/blood-2017-11-814244. Epub 2018 Apr 9.

PMID:
29632024
15.

High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease.

Yanir AD, Hanson IC, Shearer WT, Noroski LM, Forbes LR, Seeborg FO, Nicholas S, Chinn I, Orange JS, Rider NL, Leung KS, Naik S, Carrum G, Sasa G, Hegde M, Omer BA, Ahmed N, Allen CE, Khaled Y, Wu MF, Liu H, Gottschalk SM, Heslop HE, Brenner MK, Krance RA, Martinez CA.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1643-1650. doi: 10.1016/j.bbmt.2018.03.029. Epub 2018 Apr 6.

PMID:
29630926
16.

CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.

McClain KL, Picarsic J, Chakraborty R, Zinn D, Lin H, Abhyankar H, Scull B, Shih A, Lim KPH, Eckstein O, Lubega J, Peters TL, Olea W, Burke T, Ahmed N, Hicks MJ, Tran B, Jones J, Dauser R, Jeng M, Baiocchi R, Schiff D, Goldman S, Heym KM, Wilson H, Carcamo B, Kumar A, Rodriguez-Galindo C, Whipple NS, Campbell P, Murdoch G, Kofler J, Heales S, Malone M, Woltjer R, Quinn JF, Orchard P, Kruer MC, Jaffe R, Manz MG, Lira SA, Parsons DW, Merad M, Man TK, Allen CE.

Cancer. 2018 Jun 15;124(12):2607-2620. doi: 10.1002/cncr.31348. Epub 2018 Apr 6.

17.

Fire behind the fury: IL-18 and MAS.

McClain KL, Allen CE.

Blood. 2018 Mar 29;131(13):1393-1394. doi: 10.1182/blood-2018-02-828186. No abstract available.

18.

High-Throughput Kinetic Analysis for Target-Directed Covalent Ligand Discovery.

Craven GB, Affron DP, Allen CE, Matthies S, Greener JG, Morgan RML, Tate EW, Armstrong A, Mann DJ.

Angew Chem Int Ed Engl. 2018 May 4;57(19):5257-5261. doi: 10.1002/anie.201711825. Epub 2018 Mar 26.

19.

RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.

Hogstad B, Berres ML, Chakraborty R, Tang J, Bigenwald C, Serasinghe M, Lim KPH, Lin H, Man TK, Remark R, Baxter S, Kana V, Jordan S, Karoulia Z, Kwan WH, Leboeuf M, Brandt E, Salmon H, McClain K, Poulikakos P, Chipuk J, Mulder WJM, Allen CE, Merad M.

J Exp Med. 2018 Jan 2;215(1):319-336. doi: 10.1084/jem.20161881. Epub 2017 Dec 20.

20.

N-Acetyltransferase 2 Genotype-Dependent N-Acetylation of Hydralazine in Human Hepatocytes.

Allen CE, Doll MA, Hein DW.

Drug Metab Dispos. 2017 Dec;45(12):1276-1281. doi: 10.1124/dmd.117.078543. Epub 2017 Oct 10.

21.

Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas.

Yeh EA, Greenberg J, Abla O, Longoni G, Diamond E, Hermiston M, Tran B, Rodriguez-Galindo C, Allen CE, McClain KL; North American Consortium for Histiocytosis.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26784. Epub 2017 Sep 25. Review.

PMID:
28944988
22.

A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility.

Peckham-Gregory EC, Chakraborty R, Scheurer ME, Belmont JW, Abhyankar H, Sengal AG, Scull BP, Eckstein O, Zinn DJ, Mayer L, Shih A, Merad M, Parsons DW, McClain KL, Lupo PJ, Allen CE.

Blood. 2017 Nov 16;130(20):2229-2232. doi: 10.1182/blood-2017-08-800565. Epub 2017 Sep 21. No abstract available.

23.

Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, Malawi.

El-Mallawany NK, Mutai M, Mtete I, Gopal S, Stanley CC, Wasswa P, Mtunda M, Chasela M, Kamiyango W, Villiera J, Fedoriw Y, Montgomery ND, Liomba GN, Kampani C, Krysiak R, Westmoreland KD, Kim MH, Slone JS, Scheurer ME, Allen CE, Mehta PS, Kazembe PN.

Glob Pediatr Health. 2017 Jun 23;4:2333794X17715831. doi: 10.1177/2333794X17715831. eCollection 2017.

24.

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

Héritier S, Hélias-Rodzewicz Z, Chakraborty R, Sengal AG, Bellanné-Chantelot C, Thomas C, Moreau A, Fraitag S, Allen CE, Donadieu J, Emile JF.

Mol Cancer. 2017 Jul 6;16(1):115. doi: 10.1186/s12943-017-0690-z.

25.

A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults.

Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, Rojas-Hernandez C, Blechacz B, Wang S, Minkov M, Jordan MB, La Rosée P, Kantarjian HM.

Cancer. 2017 Sep 1;123(17):3229-3240. doi: 10.1002/cncr.30826. Epub 2017 Jun 16. Review.

26.

Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases.

McNally JP, Millen SH, Chaturvedi V, Lakes N, Terrell CE, Elfers EE, Carroll KR, Hogan SP, Andreassen PR, Kanter J, Allen CE, Henry MM, Greenberg JN, Ladisch S, Hermiston ML, Joyce M, Hildeman DA, Katz JD, Jordan MB.

Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):E4782-E4791. doi: 10.1073/pnas.1703683114. Epub 2017 May 22.

27.

Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma.

Chakraborty R, Hampton OA, Abhyankar H, Zinn DJ, Grimes A, Skull B, Eckstein O, Mahmood N, Wheeler DA, Lopez-Terrada D, Peters TL, Hicks JM, Elghetany T, Krance R, Poulikakos PI, Merad M, McClain KL, Allen CE, Parsons DW.

Oncotarget. 2017 Jul 11;8(28):46065-46070. doi: 10.18632/oncotarget.17521.

28.

Target and Agent Prioritization for the Children's Oncology Group-National Cancer Institute Pediatric MATCH Trial.

Allen CE, Laetsch TW, Mody R, Irwin MS, Lim MS, Adamson PC, Seibel NL, Parsons DW, Cho YJ, Janeway K; Pediatric MATCH Target and Agent Prioritization Committee.

J Natl Cancer Inst. 2017 May 1;109(5). doi: 10.1093/jnci/djw274.

29.

Pediatric oncology enters an era of precision medicine.

Seibel NL, Janeway K, Allen CE, Chi SN, Cho YJ, Glade Bender JL, Kim A, Laetsch TW, Irwin MS, Takebe N, Tricoli JV, Parsons DW.

Curr Probl Cancer. 2017 May - Jun;41(3):194-200. doi: 10.1016/j.currproblcancer.2017.01.002. Epub 2017 Feb 1.

PMID:
28343740
30.

The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis.

Ballester LY, Cantu MD, Lim KPH, Sarabia SF, Ferguson LS, Renee Webb C, Allen CE, McClain KL, Mohila CA, Punia JN, Roy A, López-Terrada DH, John Hicks M, Fisher KE.

Hematol Oncol. 2018 Feb;36(1):307-315. doi: 10.1002/hon.2388. Epub 2017 Feb 20.

PMID:
28219109
31.

Characterization of the second conserved domain in the heme uptake protein HtaA from Corynebacterium diphtheriae.

Uluisik RC, Akbas N, Lukat-Rodgers GS, Adrian SA, Allen CE, Schmitt MP, Rodgers KR, Dixon DW.

J Inorg Biochem. 2017 Feb;167:124-133. doi: 10.1016/j.jinorgbio.2016.11.027. Epub 2016 Nov 23.

32.

Evaluation of maternal and perinatal characteristics on childhood lymphoma risk: A population-based case-control study.

Peckham-Gregory EC, Danysh HE, Brown AL, Eckstein O, Grimes A, Chakraborty R, Lubega J, McClain KL, Allen CE, Scheurer ME, Lupo PJ.

Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26321. Epub 2016 Nov 28.

PMID:
27896915
33.

A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis.

Arceci RJ, Allen CE, Dunkel IJ, Jacobsen E, Whitlock J, Vassallo R, Morris SR, Portnoy A, Reedy BA, Smith DA, Noble R, Murnane A, Cornfeld M, Rodriguez-Galindo C, Heaney ML, McClain K, Vaiselbuh S.

Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26325. Epub 2016 Nov 2.

PMID:
27804235
34.

Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis.

Chakraborty R, Burke TM, Hampton OA, Zinn DJ, Lim KP, Abhyankar H, Scull B, Kumar V, Kakkar N, Wheeler DA, Roy A, Poulikakos PI, Merad M, McClain KL, Parsons DW, Allen CE.

Blood. 2016 Nov 24;128(21):2533-2537. Epub 2016 Oct 11.

35.

Hydroxyurea: a new old therapy for Langerhans cell histiocytosis.

Zinn DJ, Grimes AB, Lin H, Eckstein O, Allen CE, McClain KL.

Blood. 2016 Nov 17;128(20):2462-2465. Epub 2016 Sep 29. No abstract available.

36.

Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, Erichsen HC, Forbes LR, Gu S, Yuan B, Jhangiani SN, Muzny DM, Rødningen OK, Sheng Y, Nicholas SK, Noroski LM, Seeborg FO, Davis CM, Canter DL, Mace EM, Vece TJ, Allen CE, Abhyankar HA, Boone PM, Beck CR, Wiszniewski W, Fevang B, Aukrust P, Tjønnfjord GE, Gedde-Dahl T, Hjorth-Hansen H, Dybedal I, Nordøy I, Jørgensen SF, Abrahamsen TG, Øverland T, Bechensteen AG, Skogen V, Osnes LTN, Kulseth MA, Prescott TE, Rustad CF, Heimdal KR, Belmont JW, Rider NL, Chinen J, Cao TN, Smith EA, Caldirola MS, Bezrodnik L, Lugo Reyes SO, Espinosa Rosales FJ, Guerrero-Cursaru ND, Pedroza LA, Poli CM, Franco JL, Trujillo Vargas CM, Aldave Becerra JC, Wright N, Issekutz TB, Issekutz AC, Abbott J, Caldwell JW, Bayer DK, Chan AY, Aiuti A, Cancrini C, Holmberg E, West C, Burstedt M, Karaca E, Yesil G, Artac H, Bayram Y, Atik MM, Eldomery MK, Ehlayel MS, Jolles S, Flatø B, Bertuch AA, Hanson IC, Zhang VW, Wong LJ, Hu J, Walkiewicz M, Yang Y, Eng CM, Boerwinkle E, Gibbs RA, Shearer WT, Lyle R, Orange JS, Lupski JR.

J Allergy Clin Immunol. 2017 Jan;139(1):232-245. doi: 10.1016/j.jaci.2016.05.042. Epub 2016 Jul 16. Erratum in: J Allergy Clin Immunol. 2018 Feb;141(2):832.

37.

ALPS DNT cells: active senior living with mTOR.

Allen CE.

Blood. 2016 Jul 14;128(2):152. doi: 10.1182/blood-2016-05-713032. No abstract available.

38.

Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes.

Tamamyan GN, Kantarjian HM, Ning J, Jain P, Sasaki K, McClain KL, Allen CE, Pierce SA, Cortes JE, Ravandi F, Konopleva MY, Garcia-Manero G, Benton CB, Chihara D, Rytting ME, Wang S, Abdelall W, Konoplev SN, Daver NG.

Cancer. 2016 Sep 15;122(18):2857-66. doi: 10.1002/cncr.30084. Epub 2016 May 31.

39.

In vivo physiological recording from the lateral line of juvenile zebrafish.

Olt J, Allen CE, Marcotti W.

J Physiol. 2016 Oct 1;594(19):5427-38. doi: 10.1113/JP271794. Epub 2016 Jun 9.

40.

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM; Histiocyte Society.

Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10. Review.

41.

Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications.

Zinn DJ, Chakraborty R, Allen CE.

Oncology (Williston Park). 2016 Feb;30(2):122-32, 139. Review.

42.

Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders.

Allen CE, Parsons DW.

Hematology Am Soc Hematol Educ Program. 2015;2015:559-64. doi: 10.1182/asheducation-2015.1.559. Review.

PMID:
26637772
43.

Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis.

Allen CE, McClain KL.

Hematology Am Soc Hematol Educ Program. 2015;2015:177-82. doi: 10.1182/asheducation-2015.1.177. Review.

PMID:
26637718
44.

Heme Binding by Corynebacterium diphtheriae HmuT: Function and Heme Environment.

Draganova EB, Akbas N, Adrian SA, Lukat-Rodgers GS, Collins DP, Dawson JH, Allen CE, Schmitt MP, Rodgers KR, Dixon DW.

Biochemistry. 2015 Nov 3;54(43):6598-609. doi: 10.1021/acs.biochem.5b00666. Epub 2015 Oct 26.

45.

Cell(s) of Origin of Langerhans Cell Histiocytosis.

Collin M, Bigley V, McClain KL, Allen CE.

Hematol Oncol Clin North Am. 2015 Oct;29(5):825-38. doi: 10.1016/j.hoc.2015.06.003. Epub 2015 Aug 20. Review.

46.

Psychological Inflexibility and Psychopathology in 9-1-1 Telecommunicators.

Lilly MM, Allen CE.

J Trauma Stress. 2015 Jun;28(3):262-6. doi: 10.1002/jts.22004. Epub 2015 May 11.

PMID:
25964163
47.

How I treat Langerhans cell histiocytosis.

Allen CE, Ladisch S, McClain KL.

Blood. 2015 Jul 2;126(1):26-35. doi: 10.1182/blood-2014-12-569301. Epub 2015 Mar 31.

48.

Treatment of Langerhans cell histiocytosis: it is time to learn from the past: response to Minkov and Rodriguez-Galindo.

Allen CE, McClain KL.

Br J Haematol. 2015 Oct;171(1):150-1. doi: 10.1111/bjh.13371. Epub 2015 Mar 30. No abstract available.

49.

Selection on male sex pheromone composition contributes to butterfly reproductive isolation.

Bacquet PM, Brattström O, Wang HL, Allen CE, Löfstedt C, Brakefield PM, Nieberding CM.

Proc Biol Sci. 2015 Apr 7;282(1804):20142734. doi: 10.1098/rspb.2014.2734.

50.

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, Beltrão M, Lira SA, Heym KM, Clausen BE, Bigley V, Collin M, Manz MG, McClain K, Merad M, Allen CE.

J Exp Med. 2015 Feb 9;212(2):281. doi: 10.1084/jem.2013097701202015c. Epub 2015 Feb 2. No abstract available.

Supplemental Content

Loading ...
Support Center